Medvi, a telehealth provider specializing in GLP-1 drugs, has emerged as a significant player in the healthcare sector since its launch in September 2024. Founded by Matthew Gallagher with an initial investment of just $20,000, Medvi has utilized over a dozen AI tools, including ChatGPT and Claude, to streamline operations and enhance customer engagement.
By the end of 2025, Medvi reported sales of $401 million and had amassed a customer base of 250,000. The company achieved a net profit margin of 16.2% during the same year, showcasing its efficient business model. Gallagher noted that the “growth was insane,” reflecting the rapid acceptance of their services.
In February 2026, Medvi launched a men’s health line, which quickly attracted 50,000 customers within its first month. This expansion is part of Medvi’s strategy to diversify its offerings and tap into the growing demand for men’s health services. The positive reception of this new line indicates a strong market interest.
Analysts project that Medvi will reach $1.8 billion in sales by the end of 2026, a significant leap from its previous year’s performance. This forecast aligns with broader trends in the telehealth industry, which has seen increased adoption of digital health solutions.
Gallagher’s approach to building Medvi has drawn attention from industry leaders. Jon Lensing remarked, “Matthew’s native tongue seems to be A.I.,” highlighting Gallagher’s adept use of technology in business. Sam Altman, CEO of OpenAI, had previously predicted that AI would enable individuals to create billion-dollar companies, a vision that seems to be materializing with Medvi’s success.
Fortune noted that Medvi serves as proof that AI is enabling ultra-lean, hyper-scalable companies. With Gallagher’s brother Elliot as the sole employee, Medvi exemplifies how technology can facilitate significant growth with minimal overhead.
As Medvi continues to expand its services and customer base, industry observers are keenly watching its next moves. The company’s innovative approach and strategic use of AI tools may set new standards in the telehealth sector.
Details remain unconfirmed regarding future product launches or additional service lines, but the trajectory of Medvi suggests that it will remain a key player in the evolving landscape of digital healthcare.
